A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)

Clinical trial NCT05166109 · COMPLETED

Trial details

NCT number: NCT05166109
Sponsor: ReveraGen BioPharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Becker Muscular Dystrophy

Start date: 2022-07-07
Primary completion: 2025-08-18
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.